Ebola: Is there a hope from treatment with cardiovascular drugs?

被引：22
|
作者：
Patane, Salvatore [1 ]
机构：
[1] Cardiol Osped San Vincenzo Taormina Me Azienda Sa, I-98039 Messina, Italy
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2014年 / 177卷 / 02期
关键词：
Amiodarone; Doxazosin; Statin; Pentoxifylline; Propranolol; Verapamil; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; BACTERIAL-ENDOCARDITIS PROPHYLAXIS; HUMAN-IMMUNODEFICIENCY-VIRUS; ENDOTHELIAL GROWTH-FACTOR; ACUTE CORONARY SYNDROME; ACUTE KIDNEY INJURY; HEPATITIS-C VIRUS; SINE-QUA-NON; ATRIAL-FIBRILLATION; TISSUE FACTOR;
D O I：
10.1016/j.ijcard.2014.08.114
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：524 / 526
页数：3
相关论文
共 50 条
  • [41] Lipid lowering drugs and inflammatory changes: an impact on cardiovascular outcomes?
    Ruscica, M.
    Ferri, N.
    Macchi, C.
    Corsini, A.
    Sirtori, C. R.
    ANNALS OF MEDICINE, 2018, 50 (06) : 461 - 484
  • [42] Series: Cardiovascular outcome trials for diabetes drugs Alogliptin and EXAMINE
    Fisher, Miles
    BRITISH JOURNAL OF DIABETES, 2019, 19 (02): : 133 - 135
  • [43] Quality of Cardiovascular Drugs Prescribing in Croatia 2003-2008
    Stimac, Danijela
    COLLEGIUM ANTROPOLOGICUM, 2012, 36 : 189 - 194
  • [44] Role of New Antiplatelet Drugs on Cardiovascular Disease: Update on Cangrelor
    Lucrecia Marcano, Ana
    Luis Ferreiro, Jose
    CURRENT ATHEROSCLEROSIS REPORTS, 2016, 18 (11)
  • [45] The emergence of factor Xa inhibitors for the treatment of cardiovascular diseases: a patent review
    Pinto, Donald J. P.
    Qiao, Jennifer X.
    Knabb, Robert M.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2012, 22 (06) : 645 - 661
  • [46] Vorapaxar in the treatment of cardiovascular diseases
    Tantry, Udaya S.
    Bliden, Kevin P.
    Chaudhary, Rahul
    Novakovic, Marko
    Rout, Amit
    Gurbel, Paul A.
    FUTURE CARDIOLOGY, 2020, 16 (05) : 373 - 384
  • [47] Mineralocorticoid Receptor Antagonism for the Treatment of AF and HFpEF Preserving Hope
    DeVore, Adam D.
    Piccini, Jonathan P.
    JACC-HEART FAILURE, 2018, 6 (08) : 698 - 700
  • [48] Combinatorial screening of a panel of FDA-approved drugs identifies several candidates with anti-Ebola activities
    Du, Xiaohong
    Zuo, Xiangyang
    Meng, Fang
    Wu, Fei
    Zhao, Xin
    Li, Chunfeng
    Cheng, Genhong
    Qin, F. Xiao-Feng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 522 (04) : 862 - 868
  • [49] Eligibility of persons who inject drugs for treatment of hepatitis C virus infection
    Arain, Amber
    Robaeys, Geert
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (36) : 12722 - 12733
  • [50] Emerging drugs for the treatment of Dravet syndrome
    Brigo, Francesco
    Striano, Pasquale
    Balagura, Ganna
    Belcastro, Vincenzo
    EXPERT OPINION ON EMERGING DRUGS, 2018, 23 (04) : 261 - 269
12345